Learn More
ACROBiosystems Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (AM130)
Manufacturer: ACROBiosystems S1NM164100UG
Antibody;100UG;Human IgA1/kappa;This product can recognize SARS-CoV-2 and SARS-CoV Spike Protein RBD domainn. No cross-reactivity is deteced with Spike Protein RBD domain of other coronaviruses, including MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.;Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (AM130) is a chimeric monoclonal antibody combining the constant domains of the human IgA1 molecule with mouse variable regions.; The protein migrates as 27 kDa and 55 kDa under reducing (R) condition (SDS-PAGE).;Immobilized SARS-CoV-2 S protein RBD, His Tag (Cat. No.SPD-C52H1) at 2 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (Cat. No.S1N-M164) with a linear range of 0.24-3.9 ng/mL (QC tested).
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.